Komori
Other Disclosures7780Menicon Co.,Ltd.Electrical Equipment and Precision Instruments

Notice of the Transfer of the Operating Structure for the Fertility Supplement Business

The operator of the fertility supplement business will change from our company to 株式会社ジネコ around November 2026. Following the transfer, 株式会社ジネコ will operate the business.

Worth reading
51Recurring
Scored from 5 of 6 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Conditional
How definitive the wording is.

Announced details

Fertility supplements business
Applicable field (uses covered by this announcement)

Fertility and medical fields

Launch dateAround November 2026 (scheduled)
Relationship between the counterparty and the company
Menicon Co.,Ltd.7780
Relationship with the Company

Transferee of the operating responsibility for the fertility supplement business

Counterparty株式会社ジネコ

Based in Minato-ku, Tokyo

Impact on Business Performance

The impact on our consolidated results will be immaterial

The company does not address Contract Value / Offering price.

Announced details
ItemDetails
Names of Products / Services CoveredFertility supplements business
Counterparty株式会社ジネコ
Counterparty overviewBased in Minato-ku, Tokyo
Relationship with the CompanyTransferee of the operating responsibility for the fertility supplement business
Launch dateAround November 2026 (scheduled)
Applicable areaFertility and medical fields
Impact on Business PerformanceThe impact on our consolidated results will be immaterial
Items this document does not state (11)
Contract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleQuantitative EffectsUsage historySource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The transfer will be carried out as part of a review of the business operating structure. Going forward, the company intends to pursue initiatives that create new value, including in the medical field.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice of the Transfer of the Operating Structure for the Fertility Supplement Business | Menicon Co.,Ltd. (7780) timely disclosure | Komori